Brain Tumour Unit, IOB Institute of Oncology
Head of the Neuro-Oncology Unit, Clínic Hospital in Barcelona
Coordinator of the Clinical and Experimental Neuroimmunology research team of the August Pi i Sunyer Biomedical Research Institute (IDIBAPS).
Professor of Medicine at the University of Barcelona
Honorary Doctorate by the University of Lyon
• He is a Neuro-Oncologist that focuses his clinical activity on the diagnosis and treatment of brain tumours, particularly gliomas (astrocytoma, oligodendroglioma and glioblastoma), and the neurological complications caused by cancer. He obtained his degree in 1976 from the Autonomous University of Barcelona with the mark of excellent, and the title of Medical Doctor from the same University with “Cum Laude” in 1982. He completed a Neurology residency at the C.S.U. Bellitge, l’Hospitalet, and then a fellowship in Neuro-Oncology at the Memorial Sloan-Kettering Cancer Centre in New York from 1982 to 1985.
• In 1986, he joined the Neurology Department of the Clínic Hospital in Barcelona as neurologist, where he is currently the Head of the Department and coordinator of the Clinical and Experimental Neuroimmunology research team of the August Pi i Sunyer Biomedical Research Institute (IDIBAPS). He is also Full Professor of Medicine at the University of Barcelona and Honorary Doctor by the University of Lyon.
• In 1986, he established and is the current coordinator of the brain tumour team of the Clínic Hospital, which includes specialists in the field of neurosciences and oncology involved in the treatment of brain tumours. This model of work has been exported to many hospitals in Spain.
• Founding member and first president of the Spanish Group of Neuro-Oncology (GENO). He was a founding member and president of the European Association of Neuro-Oncology (EANO). Dr. Graus’s line of research has allowed confirming the immune hypothesis of paraneoplastic neurological syndromes that are configured as a model of anti-tumour immunity and characterising various antineuronal antibodies that are used today for the diagnosis of these syndromes. In the field of clinical research, Dr. Graus has worked on the development of combined regimens of chemo and radiotherapy for the treatment of primary cerebral lymphoma and in the study of prognostic factors in patients with malignant gliomas.